Literature DB >> 5332539

Treatment of hypertension with spironolactone. Double-blind study.

R L Wolf, M Mendlowitz, J Roboz, G P Styan, P Kornfeld, A Weigl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5332539

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  [Antihypertensive effect of spironolactone (author's transl)].

Authors:  H Liebau; W Jarosch-von Schweder
Journal:  Klin Wochenschr       Date:  1974-09-01

2.  Spironolactone.

Authors: 
Journal:  Br Med J       Date:  1967-06-17

3.  Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Ali Javaheri; Ahmed Diab; Lei Zhao; Chenao Qian; Jordana B Cohen; Payman Zamani; Anupam Kumar; Zhaoqing Wang; Christina Ebert; Joseph Maranville; Erika Kvikstad; Michael Basso; Vanessa van Empel; A Mark Richards; Robert N Doughty; Ernst Rietzschel; Karl Kammerhoff; Joseph Gogain; Peter Schafer; Dietmar A Seiffert; David A Gordon; Francisco Ramirez-Valle; Douglas L Mann; Thomas P Cappola; Julio A Chirinos
Journal:  Circ Heart Fail       Date:  2022-08-09       Impact factor: 10.447

4.  Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.

Authors:  B I Hoffbrand; C J Edmonds; T Smith
Journal:  Br Med J       Date:  1976-03-20

5.  Potassium deficiency in hypertensives treated with diuretics. Analysis of three alternative treatments by an oral test for potassium deficiency.

Authors:  K J Berg; K Gisholt; T E Wideroe
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

Review 6.  Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis.

Authors:  G Liu; X X Zheng; Y L Xu; J Lu; R T Hui; X H Huang
Journal:  J Hum Hypertens       Date:  2014-07-31       Impact factor: 3.012

7.  Maximizing diuretic therapy in resistant hypertension.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

8.  Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Armin Attar; Amir-Abbas Sadeghi; Fatemeh Amirmoezi; Kamran Aghasadeghi
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

Review 9.  Aldosterone synthase inhibitors in hypertension: current status and future possibilities.

Authors:  Milan Hargovan; Albert Ferro
Journal:  JRSM Cardiovasc Dis       Date:  2014-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.